MC
ALXN

Maverick Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Maverick Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,420
Closed -$2.1M – 868
2021
Q2 		$2.1M Sell
11,420
-18,889
-62% -$3.24M 0.02% 164
2021
Q1 		$4.63M Buy
+30,309
New +$4.69M 0.04% 78
2020
Q4 		– Sell
-10,959
Closed -$1.25M – 813
2020
Q3 		$1.25M Sell
10,959
-2,475
-18% -$267K 0.02% 220
2020
Q2 		$1.51M Buy
13,434
+11,315
+534% +$1.2M 0.03% 218
2020
Q1 		$190K Buy
+2,119
New +$208K ﹤0.01% 424
2015
Q3 		– Sell
-1,600
Closed -$289K – 133
2015
Q2 		$289K Buy
1,600
+250
+19% +$43.1K ﹤0.01% 58
2015
Q1 		$234K Buy
+1,350
New +$244K ﹤0.01% 118

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return